Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR Technology – AsiaOne
|
Singapore's IP Office to Grant Merck's Patent Application for CRISPR Technology
AsiaOne This forthcoming, fundamental patent in Singapore, entitled "CRISPR-BASED GENOME MODIFICATION AND REGULATION," covers chromosomal integration, or cutting of the chromosomal sequence of eukaryotic cells (such as mammalian and plant cells) and insertion … Singapore's IP Office to Grant MilliporeSigma's Patent Application for … |
